Foster & Motley’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Buy |
51,493
+13,268
| +35% | +$614K | 0.14% | 150 |
|
|
2025
Q1 | $2.33M | Buy |
38,225
+5,383
| +16% | +$328K | 0.15% | 143 |
|
|
2024
Q4 | $1.86M | Buy |
32,842
+6,684
| +26% | +$378K | 0.12% | 158 |
|
|
2024
Q3 | $1.35M | Sell |
26,158
-3,350
| -11% | -$173K | 0.09% | 191 |
|
|
2024
Q2 | $1.23M | Sell |
29,508
-831
| -3% | -$34.5K | 0.08% | 190 |
|
|
2024
Q1 | $1.65M | Sell |
30,339
-3,773
| -11% | -$205K | 0.11% | 166 |
|
|
2023
Q4 | $1.75M | Sell |
34,112
-9,981
| -23% | -$512K | 0.13% | 152 |
|
|
2023
Q3 | $2.56M | Sell |
44,093
-4,360
| -9% | -$253K | 0.21% | 130 |
|
|
2023
Q2 | $3.1M | Buy |
48,453
+4,026
| +9% | +$257K | 0.24% | 116 |
|
|
2023
Q1 | $3.08M | Buy |
44,427
+13,241
| +42% | +$918K | 0.25% | 107 |
|
|
2022
Q4 | $2.24M | Buy |
31,186
+3,299
| +12% | +$237K | 0.19% | 140 |
|
|
2022
Q3 | $1.98M | Buy |
27,887
+3,586
| +15% | +$255K | 0.19% | 137 |
|
|
2022
Q2 | $1.87M | Buy |
24,301
+6,527
| +37% | +$503K | 0.16% | 140 |
|
|
2022
Q1 | $1.3M | Buy |
17,774
+464
| +3% | +$33.9K | 0.1% | 172 |
|
|
2021
Q4 | $1.08M | Sell |
17,310
-6,381
| -27% | -$398K | 0.08% | 181 |
|
|
2021
Q3 | $1.4M | Buy |
23,691
+3,107
| +15% | +$184K | 0.12% | 154 |
|
|
2021
Q2 | $1.38M | Buy |
20,584
+7,414
| +56% | +$495K | 0.12% | 161 |
|
|
2021
Q1 | $831K | Buy |
13,170
+3,835
| +41% | +$242K | 0.07% | 188 |
|
|
2020
Q4 | $579K | Buy |
9,335
+220
| +2% | +$13.6K | 0.06% | 201 |
|
|
2020
Q3 | $550K | Sell |
9,115
-388
| -4% | -$23.4K | 0.06% | 187 |
|
|
2020
Q2 | $559K | Sell |
9,503
-1,789
| -16% | -$105K | 0.07% | 181 |
|
|
2020
Q1 | $629K | Buy |
11,292
+3,310
| +41% | +$184K | 0.09% | 160 |
|
|
2019
Q4 | $512K | Buy |
7,982
+3,177
| +66% | +$204K | 0.06% | 192 |
|
|
2019
Q3 | $244K | Buy |
+4,805
| New | +$244K | 0.03% | 231 |
|